Metraipolis › archive › dc_c01006797f48
Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance — Europe PMC PMID:41514589
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41514589
- DOI
- 10.3390/cancers18010076
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T10:23:44.263Z
- SHA-256 of the archived text
a824a30bbdc6ba9539c00cb3da1cb78b52e2dbaa49cfa9db6fca74131dbffd20- Stable URL of this page
https://metraipolis.com/documento/dc_c01006797f48
How to cite
Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance — Europe PMC PMID:41514589 — Europe PMC (en), https://europepmc.org/article/MED/41514589 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c01006797f48 (Metraipolis archive dc_c01006797f48, sha256 a824a30bbdc6ba9539c00cb3da1cb78b52e2dbaa49cfa9db6fca74131dbffd20)
BibTeX
@misc{dcc01006797f48,
title = {Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance — Europe PMC PMID:41514589},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41514589},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c01006797f48; sha256 a824a30bbdc6ba9539c00cb3da1cb78b52e2dbaa49cfa9db6fca74131dbffd20},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514589. Agents can read the archived copy with the MCP tool read_document.